Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Epiterna logo

Epiterna

Recent Finacing

Equity

Recent Raise

$10.9M

Epiterna is a Swiss biotech that operates a high-throughput platform to evaluate drugs' effects on healthy lifespan, developing translational therapies with planned companion-dog and human clinical trials.

Founded 2022
Vaud, Switzerland
11-50
Private
epiterna.com

Highlights

Focus Areas

Biotechnology

Recent Investors

Prima Materia logo

Financials

$10.9M

Total Raised

1

Funding round

1

Investor


Team

Upgrade to view the team

See the team members at Epiterna.